Machine learning based seizure classification and digital biosignal analysis of ECT seizures
- PMID: 39984540
- PMCID: PMC11845479
- DOI: 10.1038/s41598-025-88238-3
Machine learning based seizure classification and digital biosignal analysis of ECT seizures
Abstract
While artificial intelligence has received considerable attention in various medical fields, its application in the field of electroconvulsive therapy (ECT) remains rather limited. With the advent of digital seizure collection systems, the development of novel ECT seizure quality metrics and treatment guidance systems in particular will require cutting-edge digital seizure analysis. Using artificial intelligence will offer more analytical degrees of freedom and could play a key role in enhancing the precision of currently available procedures. To this end, we developed the first machine learning (ML) framework that can classify ictal and non-ictal EEG segments, accurately identifying seizure endpoints-a critical step in deriving seizure quality parameters-and computing these metrics at least as reliable as existing precomputed scores. The ML model retained in this study effectively discriminated ictal from non-ictal EEG segments with 89% accuracy, precision, and sensitivity. The reproduced ECT quality parameters showed correlations up to ϱ = 0.99 (p < 0.01) with the pre-calculated values from the stimulation device and did not significantly differ from the reference values. Mean seizure duration differences were 0.23 ± 15.59 s compared to the expert rater and 0.28 ± 16.19 s compared to the stimulation device. The study highlights the potential of integrating ML into the field of ECT and emphasizes the critical role of a highly sensitive seizure detection method in reliably determining seizure duration and deriving subsequent quality indices, paving the way for more individualized treatment strategies and novel approaches to determine seizure quality.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: RH has received speaker or advisor honoraria from Atheneum, Boehringer Ingelheim, Janssen and Rovi. MK, MKi, AP and NF have no competing interests to declare. Ethics declarations: Due to the retrospective nature of this study of anonymized patient records, the Internal Review Board of the University Hospital Bonn waived the need of obtaining informed consent and approval. Data collection and methods were performed in accordance with local laws and regulations.
Figures



References
-
- Herrman, H. et al. Time for united action on depression: a Lancet-world psychiatric association commission. Lancet399, 957–1022 (2022). - PubMed
-
- Pérez-Sola, V. et al. Economic impact of treatment-resistant depression: A retrospective observational study. J. Affect. Disorder.295, 578–586 (2021). - PubMed
-
- Bayes, A. J. & Parker, G. B. Comparison of guidelines for the treatment of unipolar depression: A focus on pharmacotherapy and neurostimulation. Acta Psychiatr. Scand137, 459–471 (2018). - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical